StockWatch
·

LINCOLN PHARMACEUTICALS LTD. Q1 FY26 Results

LINCOLNQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue154.078.4%
Total Income169.345.0%
Expenditure133.957.7%
PBT35.39117.8%
Net Profit27.68139.1%
OPM15.45%0.44pp
NPM16.34%9.16pp
EPS13.82139.1%
View full financials

Informational and educational content only. Not investment advice.